HealthEquity, Inc. (HQY) fair value analysis

Nasdaq · Updated 2026-09-07

HealthEquity, Inc. is a healthcare technology company that provides cloud-based platforms and services for health savings accounts, flexible spending accounts, and other consumer-directed benefits. The company operates in the United States, serving employers, health plans, and individual consumers through its digital ecosystem.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, HQY is trading at more than a 25% discount to estimated fair value.

HQY currently ranks #22 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $104.36
Sector: Healthcare
12-month range: $77.93–$104.36

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: C
Momentum grade: A
Leverage: Low
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range

What our data shows for HQY

Our model validated 17 trailing price-to-earnings windows for HQY, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $77.93–$104.36.
The 14-day relative strength index sits at a neutral 36.
4 of the last 12 weekly snapshots showed positive price momentum.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for HQY
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent HQY news

TickrTrends' derived news-sentiment signal for HQY is currently leaning positive, computed from recent coverage.

HealthEquity’s (HQY) Health Savings Engine Hits A New Gear (finance.yahoo.com, 2026-09-01)
TickrTrends take: HealthEquity operates in the Healthcare sector and is currently assessed as undervalued according to TickrTrends analysis. The company's progress with its Health Savings Engine represents operational momentum that valuation-focused investors should monitor to determine whether current market pricing reflects the company's improving capabilities and growth trajectory. Given the undervalued designation, developments in the Health Savings Engine's performance could become relevant to tracking whether the valuation gap narrows as the market reassesses the company's competitive position.
HQY Maintained by Deutsche Bank -- Price Target Raised to $142 (gurufocus.com, 2026-08-31)
TickrTrends take: Deutsche Bank's decision to maintain its position on HQY while raising the price target to 142 dollars suggests analyst confidence in the company's fundamentals within the Healthcare sector. Given TickrTrends' current assessment of HQY as undervalued, this price target adjustment may indicate that the market has not yet fully reflected the company's underlying value, which warrants monitoring as institutional analyst views align with valuation metrics. Investors focused on valuation should observe whether the stock moves toward the new price target, as this could signal a convergence between analyst expectations and market pricing in the Healthcare sector.
Why HealthEquity Stock Sank This Week (finance.yahoo.com, 2026-08-30)
TickrTrends take: HealthEquity operates in the Healthcare sector and currently carries an Undervalued designation according to TickrTrends valuation analysis. The recent decline in HQY stock price may warrant attention from investors focused on valuation metrics, as downward price movements can shift the relationship between market price and underlying asset value. Valuation-focused readers should monitor whether the stock's fundamentals have changed or if the price movement represents a valuation opportunity within the current market environment.

What people are saying

Follow the HQY conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is HQY stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), HQY is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is HQY's TickrTrends verdict?

HQY's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does HQY compare to other Healthcare stocks?

HQY ranks #22 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is HQY overbought or oversold?

HQY's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

HQY vs DXCM · HQY vs HSTM · HQY vs ISRG · HQY vs MNKD · HQY vs NBIX